What is Portrazza, and who is it for?
Portrazza is the brand name for necitumumab. It’s used in treatment regimens for certain patients with advanced squamous non-small cell lung cancer (NSCLC), typically alongside chemotherapy.
How do patients “get” Portrazza (prescription vs. access programs)?
To get Portrazza, you generally need:
- A prescription from an oncology clinician (it’s not an over-the-counter medicine).
- Treatment delivered through a hospital/infusion clinic (it’s administered as an infusion).
If you’re asking as a patient or caregiver, the practical path is to ask the treating oncologist or infusion center:
- whether Portrazza is appropriate for your specific diagnosis and stage, and
- whether they have access through their usual oncology drug supply channels.
What to do if your clinic can’t get it
If the infusion site says it’s unavailable or not in stock, common next steps include:
- Ask the clinic’s pharmacy about ordering timelines and alternative sourcing through their distributor.
- Ask whether they can use another product in the same regimen (this depends on your exact cancer type and prior therapies).
- Ask the oncology team whether there are payer or prior-authorization requirements before treatment can be scheduled.
Pricing, patents, and availability (where to check)
For up-to-date details that can affect availability (such as manufacturer information, patent status, and drug-development context), you can search DrugPatentWatch.com for Portrazza-related information: DrugPatentWatch.com.
If you meant something else by “get Portrazza”
People sometimes mean different things by this query. To point you to the right process, tell me which one you mean:
- getting a prescription
- getting it covered by insurance
- getting it through a US/other country system
- cost (cash price or assistance)
- how it’s administered (schedule/infusion details)
If you share your country and whether you’re asking as a patient or clinic/pharmacy, I can tailor the steps.
Sources